- Home
- PRLD vs BIII Comparison
PRLD vs BIII Comparison
Compare PRLD & BIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.65
Company Overview
Basic Information| Metric | PRLD | BIII |
|---|---|---|
| Founded | 2016 | 2025 |
| Country | United States | Hong Kong |
| Employees | N/A | 3 |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.5M | 227.0M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRLD | BIII |
|---|---|---|
| Price | $3.65 | $9.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.67 | N/A |
| AVG Volume (30 Days) | ★ 197.9K | 54.0K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,140,000.00 | N/A |
| Revenue This Year | $320.10 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 73.43 | N/A |
| 52 Week Low | $0.61 | $9.84 |
| 52 Week High | $4.19 | $9.97 |
Technical Indicators
Market Signals| Indicator | PRLD | BIII |
|---|---|---|
| Relative Strength Index (RSI) | 62.33 | 38.06 |
| Support Level | $1.02 | N/A |
| Resistance Level | $4.10 | $9.93 |
| Average True Range (ATR) | 0.31 | 0.01 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 91.38 | 35.29 |
Price Performance
Historical Comparison PRLD
BIII
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About BIII Black Spade Acquisition III Co Class A Ordinary Shares
Black Spade Acquisition III Co is a blank check company.